Replies to post #83423 on Biotech Values

[DewDiligence]

VVUS JNJ:

…whose patent are you talking about?

I’m talking about the JNJ patent cited by genisi.

And why doesn't VVUS have much to lose...an injunction sounds like a big loss to me.

What would JNJ gain by seeking an injunction against Qnexa? Topimax is already off-patent.